BDBM346255 2-[4-(2-methylpyrazol-3-yl)pyrrolo[2,3-d]pyrimidin-7-yl]-N-(5-pyrazin-2-yl-2-pyridyl)acetamide::US10202375, Example 18
SMILES: Cn1nccc1-c1ncnc2n(CC(=O)Nc3ccc(cn3)-c3cnccn3)ccc12
InChI Key: InChIKey=IHWUNRITCVVDFL-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Protein Wnt-3a (Mus musculus) | BDBM346255 (2-[4-(2-methylpyrazol-3-yl)pyrrolo[2,3-d]pyrimidin...) | PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
Redx Pharma PLC US Patent | Assay Description Mouse L cells transfected to constitutively produce biologically active murine Wnt-3a, referred to as L-Wnt cells, were purchased from the American T... | US Patent US10202375 (2019) BindingDB Entry DOI: 10.7270/Q29W0HMN | |||||||||||
More data for this Ligand-Target Pair |